SCHEMBL2810252

SCHEMBL2810252

COCCCOc1cc(CNC2CC2)c2ccccc2c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ MCHR1 Q99705 1/20 0.36
▸ HTT P42858 5/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ GAA P10253 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ REN P00797 2/20 0.35
▸ CD274 Q9NZQ7 1/20 0.35
▸ KMT2A Q03164 4/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1518682 0.83 REN (0.41) ALDH1A1ALOX15MCHR1HTTKDM4E
SCHEMBL1518448 0.80 ALDH1A1 (0.38) ALDH1A1ALOX15MCHR1HTTKDM4E
SCHEMBL89260 0.80 HTR3E (0.44) ALDH1A1ALOX15MCHR1HTTKDM4E
SCHEMBL2806149 0.79 MEN1 (0.37) ALDH1A1KDM4EHPGDRENKMT2A
SCHEMBL13131325 0.79 HPGD (0.43) ALDH1A1KDM4EGAAHPGDREN
SCHEMBL89589 0.78 KDM4E (0.38) ALDH1A1HTTKDM4EGAACD274
SCHEMBL2810309 0.78 REN (0.47) ALDH1A1HTTKDM4EGAAREN
SCHEMBL1518660 0.78 NCF1 (0.39) ALDH1A1ALOX15HTTKDM4EGAA
SCHEMBL2805447 0.78 NPC1 (0.38) ALDH1A1KDM4EHPGDSMN1; SMN2REN
SCHEMBL13132109 0.76 KMT2A (0.39) ALDH1A1ALOX15HTTKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168952-B1 MORPHOLINE DERIVATIVES AS RENIN INHIBITORS MITSUBISHI TANABE PHARMA CORP (JP) 2017-02-15 — — EP disclosed
US-8975252-B2 Morpholine derivative SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2015-03-10 — — US disclosed
US-8975252-B2 Morpholine derivative SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2015-03-10 — — US disclosed
US-8975252-B2 Morpholine derivative SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2015-03-10 — — US disclosed
CN-101679324-B Morpholine derivatives MITSUBISHI TANABE PHARMA CORP 2012-10-03 — — CN disclosed
US-20100240644-A1 MORPHOLINE DERIVATIVE SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2010-09-23 — — US disclosed
US-20100240644-A1 MORPHOLINE DERIVATIVE SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2010-09-23 — — US disclosed
US-20100240644-A1 MORPHOLINE DERIVATIVE SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2010-09-23 — — US disclosed
CN-101679324-A Morpholine derivatives MITSUBISHI TANABE PHARMA CORP 2010-03-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240644-A1 MORPHOLINE DERIVATIVE REN, AGTR1, AGTR2 ALDH1A1 2202/4885ALOX15 3459/4885MCHR1 613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback